Keywords
Last Name
Institution

Alison Oliveto

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPsychiatry, College of Medicine
DivisionPSY Center for Addiction Research
Address441 Psychiatric Research Institute
4224 Shuffield Dr.
Mail Slot # 843
Little Rock AR 72205
Phone501-526-8441
vCardDownload vCard

    Collapse Research Funds 
    Collapse principal investigator
    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 1 R01 DA039088-01 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-02 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-03 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-04 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-05 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-05 - Total direct costs: $2,132,863 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Buprenorphine Detoxification Outcomes with Isradipine - Award Number: 1 R21 DA035325-01 - Total direct costs: $275,000 - Start Date: 2013-04-15

    Pass Through Agency: Dartmouth College - Funding Agency: NIH/Nat. Inst. on Alcohol Abuse & Alcoholism - Title: Family Bases Contingency Management for Adolescent Alcohol Abuse - Award Number: 7 R01 AA016917-06 - Total direct costs: $22,928 - Start Date: 2012-06-05

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Impact of CYP2D6 Phenotype on Response to Methamphetamine in Humans - Award Number: 1 R21 DA031837-01A1 - Total direct costs: $392,501 - Start Date: 2012-05-01


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bashiri M, Mancino MJ, Stanick VA, Thostenson J, Kosten TR, Oliveto AH. Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials. Am J Addict. 2017 Dec; 26(8):807-814. PMID: 29115703.
      View in: PubMed
    2. Bashiri M, Greenfield LJ, Oliveto A. Telemedicine Interest for Routine Follow-Up Care Among Neurology Patients in Arkansas. Telemed J E Health. 2016 Jun; 22(6):514-8. PMID: 26684500.
      View in: PubMed
    3. Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. J Clin Psychopharmacol. 2014 Apr; 34(2):234-9. PMID: 24525654; PMCID: PMC4068618.
    4. Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, Oliveto AH. Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure. Exp Clin Psychopharmacol. 2013 Aug; 21(4):294-302. PMID: 23855333; PMCID: PMC3972066.
    5. Atkinson TS, Sanders N, Mancino M, Oliveto A. Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients. J Addict Med. 2013 Jul-Aug; 7(4):243-8. PMID: 23648640; PMCID: PMC3737260.
    6. Oliveto A, Mancino M, Sanders N, Cargile C, Benjamin Guise J, Bickel W, Brooks Gentry W. Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. Eur J Pharmacol. 2013 Sep 05; 715(1-3):424-35. PMID: 23524089; PMCID: PMC3759565.
    7. Oliveto A, Poling J, Mancino MJ, Williams DK, Thostenson J, Pruzinsky R, Gonsai K, Sofuoglu M, Gonzalez G, Tripathi S, Kosten TR. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction. 2012 Jan; 107(1):131-41. PMID: 21707811; PMCID: PMC3237722.
    8. Mancino MJ, Gentry BW, Feldman Z, Mendelson J, Oliveto A. Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study. Am J Drug Alcohol Abuse. 2011 Mar; 37(2):131-6. PMID: 21219261; PMCID: PMC3063384.
    9. Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend. 2011 Jan 15; 113(2-3):184-91. PMID: 20828943; PMCID: PMC3005977.
    10. Oliveto A, Gentry WB, Pruzinsky R, Gonsai K, Kosten TR, Martell B, Poling J. Behavioral effects of gamma-hydroxybutyrate in humans. Behav Pharmacol. 2010 Jul; 21(4):332-42. PMID: 20526195; PMCID: PMC2911496.
    11. Mancino MJ, McGaugh J, Feldman Z, Poling J, Oliveto A. Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis. Am J Addict. 2010 Mar-Apr; 19(2):169-77. PMID: 20163389; PMCID: PMC3472706.
    12. Oliveto A, Pruzinsky R, Poling J, Gentry WB, Martell B, Gonsai K, Kosten TR. Behavioral effects of GHB in humans. Behavioural Pharmacology. 2010; 21(4):332-42.
    13. McGaugh J, Mancino MJ, Feldman Z, Chopra MP, Gentry WB, Cargile C, Oliveto A. Open-label pilot study of modafinil for methamphetamine dependence. J Clin Psychopharmacol. 2009 Oct; 29(5):488-91. PMID: 19745650; PMCID: PMC3610177.
    14. Chopra MP, Feldman Z, Mancino MJ, Oliveto A. Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis. Pharmacol Biochem Behav. 2008 Oct; 90(4):787-96. PMID: 18585405; PMCID: PMC2577173.
    15. Chopra M.P, Feldman Z.L, Mancino M.J, Oliveto A. Response to naloxone versus placebo in opioid-dependent humans responding under a naloxone discrimination procedure: influences of sex and opioid maintenance dose. Pharmacology, Biochemistry and Behavior. 2008; 90(4):787-96.
    16. Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Oliveto A, Kosten TR. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Exp Clin Psychopharmacol. 2007 Oct; 15(5):453-60. PMID: 17924779.
      View in: PubMed
    17. Poling J, Pruzinsky R, Kosten TR, Gonsai K, Sofuoglu M, Gonzalez G, Oliveto A. Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. Am J Addict. 2007 May-Jun; 16(3):187-94. PMID: 17612822.
      View in: PubMed
    18. González G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, Kosten TR. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 2007 Feb 23; 87(1):1-9. PMID: 16930857.
      View in: PubMed
    19. Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology. 2006 Mar; 31(3):644-50. PMID: 16123763.
      View in: PubMed
    20. Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006 Feb; 63(2):219-28. PMID: 16461866.
      View in: PubMed
    21. Oliveto A, Poling J, Sevarino KA, Gonsai KR, McCance-Katz EF, Stine SM, Kosten TR. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend. 2005 Aug 01; 79(2):157-65. PMID: 16002025.
      View in: PubMed
    22. Kosten T, Sofuoglu M, Poling J, Gonsai K, Oliveto A. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response. Am J Addict. 2005 Jan-Feb; 14(1):8-17. PMID: 15804873.
      View in: PubMed
    23. Hughes JR, Oliveto AH, Riggs R, Kenny M, Liguori A, Pillitteri JL, MacLaughlin MA. Concordance of different measures of nicotine dependence: two pilot studies. Addict Behav. 2004 Nov; 29(8):1527-39. PMID: 15451122.
      View in: PubMed
    24. Oliveto A, Poling J, Kosten TR, Gonsai K. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure. Eur J Pharmacol. 2004 May 03; 491(2-3):157-68. PMID: 15140632.
      View in: PubMed
    25. Gonzalez G, Oliveto A, Kosten TR. Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother. 2004 Apr; 5(4):713-25. PMID: 15102558.
      View in: PubMed
    26. Kosten T, Falcioni J, Oliveto A, Feingold A. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. Am J Addict. 2004 Mar-Apr; 13(2):191-201. PMID: 15204669.
      View in: PubMed
    27. Kosten T.R, Falcioni J, Oliveto A, Feingold A. Depression predicts poor treatment response with desipramine and methadone or buprenorphine among cocaine and opioid dependent patients. American Journal on the Addictions. 2004; 13(2):191-201.
    28. Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction. 2003 Nov; 98(11):1625-32. PMID: 14616189.
      View in: PubMed
    29. Gonzalez G, Feingold A, Oliveto A, Gonsai K, Kosten TR. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. Am J Drug Alcohol Abuse. 2003 Aug; 29(3):497-514. PMID: 14510037.
      View in: PubMed
    30. Oliveto A, Benios T, Gonsai K, Feingold A, Poling J, Kosten TR. D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure. Exp Clin Psychopharmacol. 2003 Aug; 11(3):237-46. PMID: 12940503.
      View in: PubMed
    31. Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav. 2003 Jul; 75(4):801-8. PMID: 12957222.
      View in: PubMed
    32. Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend. 2003 Jun 05; 70(3):315-25. PMID: 12757969.
      View in: PubMed
    33. Kosten T, Poling J, Oliveto A. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients. Addiction. 2003 May; 98(5):665-71. PMID: 12751984.
      View in: PubMed
    34. Kosten TR, Oliveto A, Sevarino KA, Gonsai K, Feingold A. Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug Alcohol Depend. 2002 Apr 01; 66(2):173-80. PMID: 11906804.
      View in: PubMed
    35. Feingold A, Oliveto A, Schottenfeld R, Kosten TR. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. Am J Addict. 2002; 11(2):111-23. PMID: 12028741.
      View in: PubMed
    36. Gonzalez G, Oliveto A, Kosten TR. Treatment of heroin (diamorphine) addiction: current approaches and future prospects. Drugs. 2002; 62(9):1331-43. PMID: 12076182.
      View in: PubMed
    37. Oliveto A, Sevarino K, McCance-Katz E, Feingold A. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure. Pharmacol Biochem Behav. 2002 Jan-Feb; 71(1-2):85-96. PMID: 11812511.
      View in: PubMed
    38. Oliveto A.H, Rosen M, Kosten T.A, Hameedi F, Woods S, Kosten T.R. Naloxone discrimination in opioid-dependent humans under a novel-response discrimination procedure. Experimental and Clinical Psychopharmacology. 1998; (6):169-178.
    39. Oliveto A.H, Kosten T. R. New Treatments for Opiate Dependence. Buprenorphine. 1997.
    40. Hughes J.H, Oliveto A.H, Higgins S.T, Bickel W.K, Terry S.Y. Saying vs. doing and other methodological issues in the study of human drug self-administration. Experimental and Clinical Psychopharmacology. 1996; (4):234-238.
    41. Best S.E, Oliveto A.H, Kosten T.R. Opioid Addiction: Recent Advances in Detoxification and Maintenance Therapy. CNS Drugs. 1996; (6):301-304.
    42. Kamien JB, Bickel WK, Oliveto AH, Higgins ST, Hughes JR, Richards AT, Badger GJ. Placebo-effects contribute to differences in the acquisition of drug discrimination by humans: a retrospective analysis. Behav Pharmacol. 1995; 6(2):187 - 194.
    43. Hale K.L, Hughes J.R, Oliveto A.H, Higgins S.T. Caffeine self-administration and subjective effects in adolescents. Experimental and Clinical Psychopharmacology. 1995; (3):364-370.
    44. Hughes, J.R, Oliveto A.H, Bickel W.K, Higgins S.T, Badger G.J. The ability of low doses of caffeine to serve as reinforcers in humans: A replication. Experimental and Clinical Psychopharmacology. 1995; (3):1-6.
    45. Kamien JB, Bickel WK, Oliveto AH, Smith BJ, Higgins ST, Hughes JR, Badger GJ. Triazolam discrimination by humans under a novel response procedure: effects of buspirone and lorazepam. Behav Pharmacol. 1994; 5(3):315 - 325.
    46. Oliveto A.H, Kosten T.R, Schottenfeld R, Ziedonis D, Falcioni J. Cocaine use in buprenorphine- vs methadone-maintained cocaine users. American Journal of Addictions. 1994; (3):43-48.
    47. Oliveto AH, Bickel WK, Hughes JR, Terry SY, Higgins ST, Badger GJ. Pharmacological specificity of the caffeine discriminative stimulus in humans: effects of theophylline, methylphenidate and buspirone. Behav Pharmacol. 1993; 4(3):237 - 246.
    48. McGaugh, J.D., Mancino, M., Gentry, W.B., Chopra, M., Cargile, C., Oliveto A. Open label modafinil for methamphetamine dependence: Safety and tolerability. 70th Annual Meeting of the College on Problems of Drug Dependence.
    49. Oliveto A, Feldman Z, Mancino, M.J. Alcohol dependence diagnosis influences response to disulfiram in dually cocaine- and opioid-dependent humans maintained on methadone. 70th Annual Meeting of the College on Problems of Drug Dependence.
    50. Mancino, M.J., Feldman, Z., Oliveto A. Gender differences in response to disulfiram treatment for cocaine dependence in methadone-stabilized opioid- and cocaine-dependent individuals. 70th Annual Meeting of the College on Problems of Drug Dependence.
    Oliveto's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _